Healthcare
Live Price
Offline$0.85
+6.25% today
1Y Change
-25.15%
Window
Jun 20, 2025 → Jun 10, 2026
Coverage: 244 bars · Jun 20, 2025 → Jun 10, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Traws Pharma, Inc. (TRAW) is a Healthcare stock with a market cap of $10.00M and listed on NASDAQ. The stock last traded around $0.85 and down 25.1% across the available one-year price window (Jun 20, 2025 → Jun 10, 2026). Baseline metrics include revenue growth of +1134.5%, EPS growth of +102.4%, a dividend yield of 0.0%. What stands out right now is revenue +1134.5%, EPS +102.4%, free cash flow +30.3% with operating margin -190.1% and ROIC 1002.6%. Valuation sits in the middle of the pack at price/sales 4.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines TRAW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TRAW
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TRAW Max Drawdown
-65.18%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TRAW and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.